Clinical trials for two COVID-19 small molecule drugs to kick off this year: Chinese scientist – Global Times

As the innovative development of the pharmaceutical industry is becoming another strategic commanding height of the game between …
As the tension between Russia and Ukraine escalates, Chinese pharmaceutical companies are evaluating the potential impact on the …
The National Medical Products Administration (NMPA) announced on its official website Saturday it has given conditional approval for …

source

Add a Comment

Your email address will not be published. Required fields are marked *